Item 1.01 Entry into a Material Definitive Agreement.
On
Advances under the Note will be made in three tranches. The principal amount of
the first tranche, which was advanced on the Effective Date, was
The Company issued to the Investor five-year warrants ("Warrants") to purchase
94,631 shares of the Company's common stock at the closing of the first tranche,
and will issue Warrants to purchase 92,700 shares at the closing of each of the
second and third tranches. The Warrants are exercisable beginning on the sixth
month anniversary of the issuance date at an exercise price equal
The foregoing description of the Purchase Agreement, Note, Security Agreement and Warrants is qualified in its entirety by reference to such documents, which are filed as Exhibits 10.1, 10.2, 10.3 and 4.1, respectively, to this Current Report, which are incorporated herein by reference.
Item 3.02 Unregistered Sales of
The disclosure in Item 1.01 is incorporated herein by this reference. The issuance of the Note, the Warrant and the Inducement Shares at the first tranche closing of the transactions contemplated by the Purchase Agreement, and the Warrants to be issued at the second and third tranche closings, were not and will not be registered under the Securities Act of 1933, as amended (the "Securities Act"). For these issuances, the Company relied on the exemption from federal registration under Section 4(a)(2) of the Securities Act and/or Rule 506 promulgated thereunder, based on the Company's belief that the offer and sale of such securities has not and will not involve a public offering.
Item 9.01. Financial Statements and Exhibits.
(a) Not applicable. (b) Not applicable. (c) Not applicable. (d) Exhibits. Exhibit No. Description 4.1 Form of Common Stock Purchase Warrant issued toOasis Capital, LLC under Security Purchase Agreement datedFebruary 5, 2020 10.1 Securities Purchase Agreement datedFebruary 5, 2020 by and betweenPredictive Oncology Inc. andOasis Capital, LLC 10.2 Senior Secured Promissory Note dated as fFebruary 5, 2020 10.3 Security Agreement datedFebruary 5, 2020 by and betweenPredictive Oncology Inc. andOasis Capital, LLC
© Edgar Online, source